Atlas Trials

Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours

Clinical trial NCT00220168 · COMPLETED

Trial details

NCT number
NCT00220168
Sponsor
Royal Marsden NHS Foundation Trust
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Upper Gastrointestinal Tumours
Start date
2003-01-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.